Emcure Pharma launches weight loss drug |
Emcure Pharmaceuticals on Monday launched Poviztra, a second brand of Novo Nordisk’s semaglutide injection for weight management, across India. With the launch, Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra in the country.
The drug will be priced starting at Rs 8,790 per month for four weekly doses, around 15–20% lower than Novo Nordisk’s Wegovy. Novo Nordisk had cut Wegovy prices by 37% about two months ago. Novo will be manufacturing Poviztra, while Emcure will be distributing and commercialising the drug and leveraging its........